GDOC ISSUER
The Goldman Sachs Innovate Health ETF (GDOC) is managed by Goldman Sachs Asset Management, L.P. (GSAM) and seeks to invest, under normal circumstances, at least 80% of its net assets in equity investments in both U.S. and non-U.S. healthcare companies. GSAM defines health care companies as those within the healthcare sector, focusing on innovative firms driving advancements in genomics, precision medicine, technology-enabled procedures, and digital healthcare. The ETF aims to identify companies at various growth stages, from early innovators to dominant businesses, with a strong emphasis on those contributing to key healthcare innovation themes.
GDOC DIVIDEND
The Goldman Sachs Innovate Health Care ETF (GDOC) focuses on investing in innovative health care companies. While its primary objective is not dividend income, GDOC's dividend distribution is influenced by the performance and dividend policies of the health care companies within its portfolio. Dividends are typically distributed on a regular basis, reflecting the financial health and profitability of the underlying companies. As GDOC emphasizes health care innovation in areas such as genomics, precision medicine, technology-enabled procedures, and digital healthcare, investors may potentially benefit from both capital appreciation and some dividend returns.
GDOC TRACKING
The GDOC Tracking ETF, managed by Goldman Sachs Asset Management, seeks to capture the potential of companies revolutionizing the healthcare sector. The fund primarily invests in U.S. and non-U.S. health care companies engaged in pioneering advancements in genomics, precision medicine, technology-enabled procedures, and digital healthcare. By identifying companies across various growth stages, from early innovators to industry leaders, GDOC aims to provide investors with exposure to healthcare firms driving innovation and efficiency in the ever-evolving healthcare landscape. The ETF's portfolio may include equity investments, ADRs, EDRs, GDRs, as well as underlying ETFs and other instruments, offering a diversified approach to healthcare innovation.
GDOC CORRELATION
The correlation aspect of the Goldman Sachs Innovate Health Care ETF (GDOC) is closely tied to its investment objective, which focuses on companies driving innovation in the healthcare sector. Given its thematic approach, GDOC may exhibit correlations with specific subsectors such as genomics, precision medicine, technology-enabled procedures, and digital healthcare. Investors can leverage these correlations to gain insights into the performance of innovative healthcare companies and make informed investment decisions.
GDOC SECTOR
The Goldman Sachs Innovate Health Care ETF (GDOC) primarily focuses on the healthcare sector, investing at least 80% of its net assets in equity investments in both U.S. and non-U.S. healthcare companies. The fund aims to target companies that are driving innovation within the healthcare industry, particularly in fields such as genomics, precision medicine, technology-enabled procedures, and digital healthcare. GDOC is designed to provide investors exposure to the rapidly evolving and transformative healthcare landscape, with a concentration on companies aligned with key themes associated with healthcare innovation. However, it's important to note that GDOC is a non-diversified fund, which means it may invest a larger percentage of its assets in fewer issuers than diversified funds, potentially presenting higher risk and return opportunities.
GDOC EXPOSURE
The exposure characteristic of the GDOC ETF (Example ETF) is focused on providing investors with exposure to innovative companies in the healthcare sector. This ETF seeks to invest in companies that are driving innovation in healthcare, particularly in the fields of genomics, precision medicine, technology-enabled procedures, and digital healthcare. It aims to identify companies at various growth stages, including dominant businesses with strong competitive advantages, early innovators, and companies that enable new treatments or technologies. GDOC''s exposure is aligned with key themes associated with healthcare innovation, providing investors with an opportunity to participate in the growth potential of these innovative sectors.
3 min read
